Sygnia founder Magda Wierzycka lifts lid on how her company bought into Oxford’s Covid-19 vaccine

Magda Wierzycka – CEO of Sygnia, bought shares in OSI, a company that transforms patents from Oxford University into viable businesses. OSI has shares in Vaccitech, a company ahead of the race in the Covid-19 vaccine.

Magda Wierzycka - CEO of Sygnia, bought shares in OSI, a company that transforms patents from Oxford University into viable businesses. OSI has shares in Vaccitech, a company ahead of the race in the Covid-19 vaccine.

This article is exclusive to Biznews Premium. Members please login here. Not yet subscribed? Taste before you eat by signing up here for a half price 30 day trial (card details required).